illuminem logo
illuminem logo
  • Rankings
  • Use Cases
  • Pricing
  • Media
  • More
illuminem logo

About illuminem

AboutCareersBecome a Thought Leader

Advertising

Advertise with usPromote EventsOur Reach

Support

FAQsContact Us
Terms & Privacy Policy

© 2026 illuminem. All rights reserved. Various trademarks held by their owners.

  1. Home
  2. ›
  3. Industries
  4. ›
  5. health care
  6. ›
  7. Suheung
Company logo

Suheung | Sustainability Performance

https://www.suheung.com/?lang=eng

Manufactures empty hard capsules for pharmaceuticals and health supplements.

1973

South Korea

501 - 1,000 employees

Pharmaceuticals

$500M - 1B in revenue

$25M - 100M in profitability

Submit or report inaccurate dataDownload Company Insights

Sustainability Ranking & Industry Benchmark

#2941
Overall
#33
in South Korea
#68
in Pharmaceuticals

Sustainability Maturity

​​0123456789​​%

Sustainability Intent

Available in
Scale package

Access
​​0123456789​​%

Industry Rank

291 out of 311

Overview
Governance
TargetsESG scores and Exclusions
Financial Data
Business performanceCapital & innovationAnalyst projections

View similiar companies


Company logo
Seegene

South Korea, Health Care, Biotechnology


Company logo
Shinpoong Pharm

South Korea, Health Care, Pharmaceuticals


Company logo
Alteogen

South Korea, Health Care, Biotechnology

Market cap

220.2B $, 2026▼17.5% YoY

Revenue

653.3B $, 2024▼9% YoY

R&D intensity

1.2% 2024

Controversy level


Very Low
Low
Noticeable
High
Severe
Download Controversy Analysis
Powered by illuminem

Market cap

220.2B $, 2026▼17.5% YoY

Revenue

653.3B $, FY2024▼9% YoY

EBITDA

37.5B $, FY2024▼9.1% YoY

Operating margin

5% Industry: -33▲39.6% YoY

P/E ratio

7.7 Industry: 26▲575.9% YoY

Revenue & EBITDA

$653.3BFY2024 revenue

Total Annual
Revenue & EBITDA
($ B)

Annual revenue
EBITDA
3 year change
Powered by illuminem

Margin trends


Margin as % of revenue

Gross margin
Operating margin
Net margin

Powered by illuminem

Free cashflow

18.1B 2024▼321.1% YoY

Capex

38.0B 2024▲32.9% YoY

Debt/equity ratio

1.0 Industry: 0▼NaN% YoY

R&D intensity

1.2%FY2024

R&D as % of revenue

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Return on invested capital

2.0%FY2026

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Analyst revenue estimates & actuals


Analyst consensus vs actuals
($ B)

Actual revenue
Consensus estimates
Estimate only

635.0

▼ 4.4%

2022

594.6

▼ 0.5%

2023

653.3

▼ 0.5%

2024

824.2

2027

Powered by illuminem

Environmental policy coverage

Carbon reduction policy

Not available

Human rights policy

Not available

Recycling policy

Not available

Workplace health & safety policy

Not available

6%
Independent Directors

1 out of 16 incl. management

Powered by illuminem

Overall score

0

Environment

0

Social

0

Governance

0

Exclusion screening

Adult content

Not available

Alcoholic

Not available

Animal testing

Not available

Firearms

Not available

Tobacco

Not available

Gambling

Not available

Nuclear

Not available

Powered by illuminem

Reporting

sustainability report symbol

Sustainability Report

Available

image report
Available

Sustainability employees


    Available in
    Scale package

    Access
  • Email

  • Email